Dr. Carl V. Hanson is the Head of the Retrovirus Diagnostics Section of the Viral and Rickettsial Disease Laboratory of the California Department of Health Services, Richmond, CA, which serves as California’s reference laboratory for HIV diagnostics. Dr. Hanson is also a faculty member of the University of California, Berkeley. He has been the Principal Investigator of grants from NIH and the U.S. Army for the development and evaluation of HIV vaccines and the study of HIV virology, immunology and serology. He earned his Ph.D. in Biophysics from Harvard University.
In 1994, Dr. Hanson was the first to observe that experimental AIDS vaccines based on laboratory-adapted HIV strains evoked little or no neutralizing antibodies to protect patients from infection, thereby overturning all previous work done worldwide on HIV vaccines. He serves as a scientific advisor and collaborator with UBI and its affiliate United BioPharma, and has applied his laboratory’s state-of-the-art neutralization assays to UBI’s anti-host cell approach for the development of effective HIV immunotherapeutics. Dr. Hanson is an author and co-author of over 70 scientific publications. He is a reviewer for NIH and several AIDS journals, and the Chairman of the “Neutralization Task Force” for the International AIDS Vaccine Initiative (IAVI).